368 J . Org. Chem., Vol. 66, No. 2, 2001
Hwang and Greenberg
dichloromethane (10 mL) was added diisopropylethylamine (67
mg, 0.52 mmol), followed by addition of N,N-diisopropyl-
aminocyanoethyl phosphonamidic chloride (48 mg, 0.2 mmol)
at 0 °C. After stirring for 2 h at room temperature, additional
phosphitylating reagent (16 mg, 0.07 mmol) was added to the
reaction mixture. After being stirred for an additional 2 h at
room temperature, the reaction was quenched with propan-
2-ol (0.24 g, 3.9 mmol). The solution was stirred for 1 h at room
temperature, whereupon a solution of 5% Na2CO3 (5 mL) was
added. The aqueous layer was extracted with CH2Cl2. The
combined organic layers were washed with brine, dried over
Na2SO4, and concentrated in vacuo. The crude phosphoramid-
ite was purified on silica gel (CH2Cl2/EtOAc, 10:1 to 1:1,
containing 1% Et3N) to yield a mixture of diastereomers of 2
as a pale brownish foam (0.1 g, 79%): 1H NMR (CDCl3) δ 7.70
(m, 2H), 7.42-7.25 (m, 9H), 7.06 (s, 1H), 6.86 (d, 4H, J ) 8.7
Hz), 6.14 (t, 1H, J ) 9.2 Hz), 5.97 (d, 1H, J ) 7.5 Hz, minor),
5.62 (dd, 1H, J ) 11.1, 25.5 Hz), 5.45 (m, 2H), 4.80-4.35 (m,
2H), 4.30 (d, 1H, J ) 54.3 Hz), 4.01 (s, 3H), 3.96 (s, 3H), 3.85
(m, 1H), 3.81 (s, 6H), 3.81-3.54 (m, 3H) 3.43 (m, 2H), 2.63
(m, 1H), 2.51 (m, 1H), 1.21 (m, 12H); 31P NMR (CDCl3) δ
152.44, 150.31; IR (film) 3232, 3065, 2967, 2252, 1694, 1607,
1519 cm-1; HRMS (FAB) calcd for C49H57N6O14P 985.3749 (M+
+ H), found 985.3766.
2′-O-(4-P h th a lim id obu tyl)-5′-O-(4,4′-d im eth oxytr ityl)-
u r id in e (8). A suspension of uridine (2.5 g, 10.3 mmol) and
dibutyltin oxide (2.86 g, 11.2 mmol) in methanol (500 mL) was
heated under reflux for 1 h, and the resulting clear solution
was evaporated to yield 2′,3′-O-dibutylstannyleneuridine as a
white solid.16 The crude product was dried further under high
vacuum. To a solution of 2′,3′-O-dibutylstannyleneuridine (4.92
g, 10.3 mmol) in DMF (60 mL) were added N-4-bromobutyl-
phthalimide (8.10 g, 28.7 mmol) and NaI (1.1 g, 7.3 mmol).
The reaction mixture was heated at 130-140 °C for 24 h, after
which time it was poured into a mixture of ether (100 mL)
and water (100 mL). The aqueous layer was extracted with
ether. The combined organic layers were washed with brine
and dried over Na2SO4. The solvent was removed in vacuo to
give a crude product mixture (55:45 ratio of 2′- and 3′-isomers
as determined by 1H NMR) as an oil which was used in the
next step without purification. To a solution of the mixture of
2′ and 3′-alkylated isomers, which was coevaporated with
pyridine, in pyridine (30 mL) in an ice-water bath was added
4,4′-dimethoxytrityl chloride (3.56 g, 10.5 mmol). The reaction
mixture was warmed to room temperature. After the mixture
was stirred overnight, the pyridine was removed under
reduced pressure to give a syrup, which was purified by flash
column chromatography (hexanes/EtOAc, 1:2 to 1:1, containing
1% Et3N). The 2′-alkylated product (8) eluted first as a pale
brownish foam (1.94 g, 25%), followed by the 3′-alkylated
product as a white foam (1.34 g, 18%). 2′-Alkylated product:
1H NMR (CDCl3) δ 9.70 (br, 1H), 8.09 (d, 1H, J ) 8.1 Hz),
7.86 (dd, 2H, J ) 3.0, 5.7 Hz), 7.73 (dd, 2H, J ) 3.3, 5.4 Hz),
7.45-7.20 (m, 9H), 6.85 (d, 4H, J ) 8.7 Hz), 5.99 (s, 1H), 5.31
(d, 1H, J ) 8.7 Hz), 4.52 (br, 1H), 4.09 (m, 2H), 3.94 (d, 1H, J
) 5.1 Hz), 3.83 (s, 6H), 3.78 (m, 3H), 3.60 (s, 2H), 3.03 (br,
1H), 1.86-1.66 (m, 4H); 13C NMR (CDCl3) δ 168.5, 163.7, 158.7,
150.2, 144.5, 140.1, 135.4, 135.2, 134.0, 132.1, 130.3, 130.2,
128.2, 128.1, 127.2, 123.3, 113.4, 102.1, 87.7, 87.1, 83.3, 82.7,
70.6, 68.6, 61.3, 55.4, 37.8, 26.6, 25.5; IR (film) 3467 (br), 3193
(br), 3058, 1770, 1712, 1608, 1509 cm-1; HRMS (FAB) calcd
for C42H41N3O10 747.2792 (M+), found 747.2677. 3′-Alkylated
product: 1H NMR (CDCl3) δ 9.65 (br, 1H), 7.90 (d, 1H, J )
8.1 Hz), 7.86 (dd, 2H, J ) 2.7, 5.4 Hz), 7.72 (dd, 2H, J ) 3.0,
5.4 Hz), 7.45-7.20 (m, 9H), 6.88 (d, 4H, J ) 9.0 Hz), 5.97 (d,
1H, J ) 3.9 Hz), 5.44 (d, 1H, J ) 8.1 Hz), 4.39 (t, 1H, J ) 4.2
Hz), 4.23 (m, 1H), 4.10 (m, 1H), 3.81 (s, 6H), 3.75-3.50 (m,
5H), 3.42 (m, 1H), 1.86-1.60 (m, 4H); 13C NMR (CDCl3) δ
168.5, 163.4, 158.7, 150.7, 144.3, 140.2, 135.4, 135.2, 134.0,
132.1, 130.1, 128.2, 128.1, 127.2, 123.3, 113.4, 102.5, 90.0, 87.1,
81.4, 77.4, 74.0, 70.3, 62.4, 55.4, 37.6, 26.9, 25.4
the reaction mixture was heated to reflux. After 5 h, the
solvent was removed to give a crude product as a foam, which
was purified on silica gel (CH2Cl2/MeOH, 10:1, containing 1%
1
Et3N) to yield a brownish foam (1 g, 83%). H NMR (CDCl3) δ
8.15 (d, 1H, J ) 7.8 Hz), 7.44-7.26 (m, 9H), 6.87 (d, 4H, J )
9.3 Hz), 6.00 (d, 1H, J ) 1.5 Hz), 5.33 (t, 1H, J ) 4.1 Hz), 4.07
(m, 1H), 3.93 (m, 2H), 3.82-3.64 (m, 8H), 3.56 (m, 2H), 2.79
(br, 2H), 1.80-1.54 (m, 4H); 13C NMR (CDCl3) δ 164.2, 158.8,
150.8, 144.5, 140.0, 135.4, 135.2, 130.3, 130.2, 128.3, 128.1,
127.2, 113.4, 102.4, 87.6, 87.2, 83.6, 82.9, 71.0, 68.7, 61.7, 55.4,
41.5, 29.5, 27.2; IR (film) 3357 (br), 3160, 3058, 2933, 1694,
1633, 1509 cm-1; HRMS (FAB) calcd for C34H39N3O8 618.2815
(M++ H), found 618.2814.
2′-O-[N-((4,5-Dim eth oxy-2-n itr oben zyl)car bon yl)-4-am i-
n obu tyl]-5′-O-(4,4′-d im eth oxytr ityl)u r id in e (9). To a solu-
tion of 4,5-dimethoxy-2-nitrobenzylchloroformate (0.20 g, 0.73
mmol) in THF (15 mL) was added diisopropylethylamine (0.14
g, 1.1 mmol), followed by addition of 2′-O-(4-aminobutyl)-5′-
O-(4,4′-dimethoxytrityl)uridine (0.34 g, 0.55 mmol) at room
temperature. After being stirred for 30 min, the reaction was
diluted with dichloromethane, washed with saturated NaHCO3
and brine, and dried over Na2SO4. The solvent was removed
to give a crude product as a brownish powder which was
purified on silica gel (CH2Cl2/EtOAc, 4:1 to 2:1, containing 1%
Et3N) to yield a white foam (0.46 g, 97%): 1H NMR (CDCl3) δ
9.98 (br s, 1H), 8.07 (d, 1H, J ) 8.4 Hz), 7.68 (s, 1H), 7.20-
7.48 (m, 9H), 7.02 (s, 1H), 6.87 (d, 4H, J ) 9.0 Hz), 5.95 (s,
1H), 5.58-5.40 (m, 3H), 5.32 (d, 1H, J ) 5.7 Hz), 4.50 (m, 1H),
4.10-3.88 (m, 9H), 3.82 (s, 6H), 3.73 (m, 1H), 3.57 (m, 2H),
3.29 (m, 2H), 3.06 (br, 1H), 1.71 (m, 4H); 13C NMR (CDCl3,) δ
163.6, 158.71, 158.68, 156.1, 153.5, 150.5, 148.1, 144.4, 140.1,
139.9, 135.3, 135.1, 130.3, 130.2, 128.2, 128.1, 127.2, 113.3,
110.5, 108.2, 102.2, 87.7, 87.1, 83.3, 82.7, 77.4, 70.9, 68.5, 63.6,
61.3, 56.52, 56.49, 55.4, 53.6, 40.9, 26.8, 26.6; IR (film) 3314
(br), 2939, 2865, 1702, 1697, 1618, 1581 cm-1
.
2′-O-[N-((4,5-Dim eth oxy-2-n itr oben zyl)car bon yl)-4-am i-
n ob u t yl]-5′-O-(4,4′-d im et h oxyt r it yl)u r id in e 3′-O-[(2-Cy-
a n oet h yl)-N,N-d iisop r op yl]p h osp h or a m id it e (3). To a
cloudy solution of 2′-O-[N-((4,5-dimethoxy-2-nitrobenzyl)car-
bonyl)-4-aminobutyl]-5′-O-(4,4′-dimethoxytrityl)uridine (0.4 g,
0.47 mmol) in dichloromethane (15 mL) was added diisopropyl-
ethylamine (0.24 g, 1.88 mmol), followed by the addition of
N,N-diisopropylaminocyanoethyl phosphonamidic chloride (0.14
g, 0.7 mmol) at 0 °C. After being stirred overnight at room
temperature, the reaction was quenched with propan-2-ol (0.79
g, 14.1 mmol) and stirred for 1 h at room temperature, at which
time a solution of 5% Na2CO3 (5 mL) was added to the reaction
mixture. The aqueous layer was extracted with CH2Cl2. The
combined organic layers were washed with brine, dried over
Na2SO4, and concentrated in vacuo. The crude phosphoramid-
ite was purified on silica gel (CH2Cl2/EtOAc, 10:1 to 1:1,
containing 1% Et3N) to yield a pale brownish foam (0.4 g, 82
mmol): 1H NMR (CDCl3) δ 8.06 (m, 1H), 7.71(s, 1H), 7.20-
7.50 (m, 9H), 7.04 (m, 1H), 6.87 (m, 4H), 5.95 (m, 1H), 5.60-
5.2 (m, 4H), 4.70-4.40 (m, 1H), 4.25 (m, 1H), 3.88-4.08 (m,
7H), 3.88-3.65 (m, 8H), 3.65-3.20 (m, 8H), 2.68 (t, 1H, J )
6.3 Hz), 2.46 (t, 1H, J ) 6.3 Hz), 1.70(br, 4H), 1.05-1.33 (m,
13H); 31P NMR (CDCl3) δ 150.67, 150.06; IR (film) 3325, 3198,
3057, 2966, 2935, 2872, 2368, 2342, 1693, 1682, 1519, 1277,
1252 cm-1; HRMS (FAB) calcd for C53H65N6O15P 1057.4324
(M++ H), found 1057.4355.
P r ep a r a tion of th e 5′-O-Dim eth oxytr ityl-3′-su ccin a to-
th ym id in e LCAA-CP G Ca p p ed by Tr im eth yla cetic An -
h yd r id e. LCAA-CPG (0.1 g), PyBOP (2.9 mg, 5.5 µmol),
diisopropylethylamine (2 mL, 12 µmol), DMAP (0.7 mg, 5.7
µmol), and 5′-O-dimethoxytrityl-3′-succinatothymidine (3.5 mg,
5.4 µmol) were combined in a screw-capped vial with aceto-
nitrile (2 mL). The reaction mixture was shaken at room
temperature for 20 min. The resin was filtered, washed with
MeOH and CH2Cl2, and then dried under high vacuum. The
amount of nucleoside loading on the support (∼30 µmol/g) was
determined by trityl analysis.19 Unreacted alkylamines were
2′-O-(4-Am in ob u t yl)-5′-O-(4,4′-d im e t h oxyt r it yl)u r i-
d in e. 2′-O-(4-Phthalimidobutyl)-5′-O-(4,4′-dimethoxytrityl)-
uridine (1.46 g, 1.95 mmol) was dissolved in methanol (30 mL).
Hydrazine monohydrate (0.50 g, 9.96 mmol) was added, and
(19) Applied Biosystems User Bulletin #13 1987, 11.